Home Sleep Screening Devices Market

Global Home Sleep Screening Devices Market: Overview

Home sleep screening devices are electronic devices used to monitor regularity of sleep. They can be used for personal use or for monitoring sleep of infants. These can be audio or video devices that keep a record of sleep and frequency of breaks in the same. This resolves the issue of physical presence required for monitoring individuals and gives accurate data regarding the depth and duration of sleep.  Sleep screening is required for a variety of conditions, most common being sleep apnea. This condition involves a continuous disruption of breathing which results in breaks in sleep. Breathing difficulties as a result of improper sleep posture and undue stress can result in sleep apnea.

A variety of chronic illnesses have also been implicated in this disease process. Diabetes is one major illness that results in sleep apnea and hence any patient of diabetes presenting with complaints of incomplete sleep needs to be monitored for sleep irregularities. Chronic illnesses are increasing world over as average age increases and the lifestyles of people push them towards developing such illnesses. The home sleep screening devices market should grow steadily owing to this trend, notes Transparency Market Research for the period of 2020 to 2030.

Global Home Sleep Screening Devices Market: Competitive Landscape

In the fragmented landscape of global home sleep screening devices market, players are active and eyeing new opportunities with a sharp focus. Players that are setting higher benchmarks include:

• Koninklijke Philips N.V.
• Garmin Ltd.
• ResMed
• Dream Sleep
• Cleveland Medical Devices Inc.
• NovaSom
• Itamar Medical Ltd.
• Ez Sleep
• ApneaMed
• SleepWorks, LLC
• VirtuOx, Inc.

These manufactures are committed to providing high quality products in an efficient manner to meet upcoming demand. Acquisition of smaller production facilities and investing in innovations in the development of better sleep screens should help meet sales targets.

Global Home Sleep Screening Devices Market: Key Trends and Drivers

• Chronic illnesses are increasing globally. The World Health Organization estimates that 57% of the global population will be afflicted with one or the other chronic illness by 2050. Chronic conditions ultimately lead to disruption of the body's natural rhythms, sleep being one of them. Sleep apnea is a major consequence of many chronic conditions. It severely affects quality of life as the individual is unable to receive good quality sleep and this function efficiently. This makes the market for home sleep screening devices lucrative as demand is expected to increase in the coming years. 
• Diabetes is a major contributor to sleep apnea. On the other hand, sleep apnea also predisposes to the development of diabetes. As people adopt unhealthy lifestyles and plunge ever more enthusiastically into work, their chances of suffering from chronic illnesses rises. The number of people with diabetes rose from 108 million in 1980 to 422 million in 2014. The global prevalence of diabetes among adults over 18 years of age rose from 4.7% in 1980 to 8.5% in 2014. These numbers bode well for the home sleep screening devices market. 

Global Home Sleep Screening Devices Market: Regional Analysis

North America and Europe are currently global leaders in the home sleep screening devices market. This can be attributed to the presence of a robust healthcare infrastructure that can quickly diagnose illnesses such as sleep apnea. Moreover, innovations are quick to develop and be adopted in this region. Sleep screening devices find increased acceptance because of this. As traditional western lifestyles are now proven to lead to chronic illnesses, the incidence of sleep disorders here should increase in the future. 

The Asia Pacific region (APAC) is expected to register the fastest growth in this market. Increased adoption of western standards of work and their lifestyle should contribute to the development of chronic illnesses. Diabetes is one illness that is rising in prevalence here yet is difficult to diagnose among the regional population. As healthcare investment rises, so should the diagnosis of this and associated conditions like sleep apnea.